Amorphous formulation development - advantages and drawbacks

Research output: Contribution to journalConference articleCommunication

Karin Kogermann, Peep Veski, Jukka Rantanen, Kaisa Naelapaa

Original languageEnglish
JournalEuropean Journal of Pharmaceutical Sciences
Volume44
Issue numbersupplement 1
Pages (from-to)22-23
Number of pages2
ISSN0928-0987
DOIs
Publication statusPublished - 24 Sep 2011

Bibliographical note

doi:10.1016/j.ejps.2011.08.002

ID: 34518028